search
Back to results

Danish Quality Assurance Project on Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in Outpatient Lung Clinics

Primary Purpose

Pulmonary Disease, Chronic Obstructive

Status
Completed
Phase
Locations
Study Type
Observational
Intervention
Education
Sponsored by
Boehringer Ingelheim
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an observational trial for Pulmonary Disease, Chronic Obstructive

Eligibility Criteria

35 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Outpatient with the diagnosis or referral diagnosis of COPD. COPD must be the primary reason for this outpatient contact (for both new patients and controls). Exclusion Criteria: Any co-morbidity that hampers the diagnosis and treatment of COPD in accordance with the COPD guidelines used locally (e.g. malignant disease, dementia or sequelae of apoplexy). Asthma without the presence of COPD

Sites / Locations

    Outcomes

    Primary Outcome Measures

    To optimise the diagnosis and treatment of COPD via a quality assurance project
    Increase the knowledge and use of diagnostic tools and treatment options
    Increase focus on COPD comorbidity

    Secondary Outcome Measures

    Full Information

    First Posted
    December 22, 2005
    Last Updated
    April 15, 2008
    Sponsor
    Boehringer Ingelheim
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00268866
    Brief Title
    Danish Quality Assurance Project on Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in Outpatient Lung Clinics
    Official Title
    Danish Quality Assurance Project on Diagnosis and Treatment of COPD in Outpatient Lung Clinics
    Study Type
    Observational

    2. Study Status

    Record Verification Date
    April 2008
    Overall Recruitment Status
    Completed
    Study Start Date
    undefined (undefined)
    Primary Completion Date
    undefined (undefined)
    Study Completion Date
    January 2007 (undefined)

    3. Sponsor/Collaborators

    Name of the Sponsor
    Boehringer Ingelheim

    4. Oversight

    5. Study Description

    Brief Summary
    Danish Quality Assurance Project on Diagnosis and Treatment of COPD in Outpatient Lung Clinics
    Detailed Description
    Study Hypothesis: Comparison(s): none

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Pulmonary Disease, Chronic Obstructive

    7. Study Design

    Enrollment
    1820 (false)

    8. Arms, Groups, and Interventions

    Intervention Type
    Behavioral
    Intervention Name(s)
    Education
    Primary Outcome Measure Information:
    Title
    To optimise the diagnosis and treatment of COPD via a quality assurance project
    Title
    Increase the knowledge and use of diagnostic tools and treatment options
    Title
    Increase focus on COPD comorbidity

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    35 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Outpatient with the diagnosis or referral diagnosis of COPD. COPD must be the primary reason for this outpatient contact (for both new patients and controls). Exclusion Criteria: Any co-morbidity that hampers the diagnosis and treatment of COPD in accordance with the COPD guidelines used locally (e.g. malignant disease, dementia or sequelae of apoplexy). Asthma without the presence of COPD
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Boehringer Ingelheim Study Coordinator
    Organizational Affiliation
    B.I. Denmark A/S
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Learn more about this trial

    Danish Quality Assurance Project on Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in Outpatient Lung Clinics

    We'll reach out to this number within 24 hrs